ENHANCE- Establishing Natural History in an Advanced New CF Care Era
Condition: Cystic Fibrosis Intervention: Other: Quality of Life Sponsors: Royal College of Surgeons, Ireland; University Hospital of Limerick; Cork University Hospital; University College Hospital Galway; Belfast Health and Social Care Trust; NHS Lothian; Alder Hey Children's NHS Foundation Trust; Manchester University NHS Foundation Trust; Newcastle-upon-Tyne Hospitals NHS Trust; Cardiff and Vale University Health Board; Royal Brompton & Harefield NHS Foundation Trust; Erasmus University Rotterdam; Medizinische Hochschule Brandenb...
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials
BioDulse II: The Effect of an Irish Seaweed Protein Extract on Glucose Control in Adults With Type 2 Diabetes
Condition: Type 2 Diabetes Interventions: Dietary Supplement: Seaweed protein; Dietary Supplement: Maltodextrin Sponsor: University of Limerick Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials
ENHANCE- Establishing Natural History in an Advanced New CF Care Era
Condition: Cystic Fibrosis Intervention: Other: Quality of Life Sponsors: Royal College of Surgeons, Ireland; University Hospital of Limerick; Cork University Hospital; University College Hospital Galway; Belfast Health and Social Care Trust; NHS Lothian; Alder Hey Children's NHS Foundation Trust; Manchester University NHS Foundation Trust; Newcastle-upon-Tyne Hospitals NHS Trust; Cardiff and Vale University Health Board; Royal Brompton & Harefield NHS Foundation Trust; Erasmus University Rotterdam; Medizinische Hochschule Brandenb...
Source: ClinicalTrials.gov - August 14, 2023 Category: Research Source Type: clinical trials
BioDulse II: The Effect of an Irish Seaweed Protein Extract on Glucose Control in Adults With Type 2 Diabetes
Condition: Type 2 Diabetes Interventions: Dietary Supplement: Seaweed protein; Dietary Supplement: Maltodextrin Sponsor: University of Limerick Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 10, 2023 Category: Research Source Type: clinical trials
ENHANCE- Establishing Natural History in an Advanced New CF Care Era
Condition: Cystic Fibrosis Intervention: Other: Quality of Life Sponsors: Royal College of Surgeons, Ireland; University Hospital of Limerick; Cork University Hospital; University College Hospital Galway; Belfast Health and Social Care Trust; NHS Lothian; Alder Hey Children's NHS Foundation Trust; Manchester University NHS Foundation Trust; Newcastle-upon-Tyne Hospitals NHS Trust; Cardiff and Vale University Health Board; Royal Brompton & Harefield NHS Foundation Trust; Erasmus University Rotterdam; Medizinische Hochschule Brandenb...
Source: ClinicalTrials.gov - August 10, 2023 Category: Research Source Type: clinical trials
BioDulse II: The Effect of an Irish Seaweed Protein Extract on Glucose Control in Adults With Type 2 Diabetes
Condition: Type 2 Diabetes Interventions: Dietary Supplement: Seaweed protein; Dietary Supplement: Maltodextrin Sponsor: University of Limerick Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 10, 2023 Category: Research Source Type: clinical trials
ENHANCE- Establishing Natural History in an Advanced New CF Care Era
Condition: Cystic Fibrosis Intervention: Other: Quality of Life Sponsors: Royal College of Surgeons, Ireland; University Hospital of Limerick; Cork University Hospital; University College Hospital Galway; Belfast Health and Social Care Trust; NHS Lothian; Alder Hey Children's NHS Foundation Trust; Manchester University NHS Foundation Trust; Newcastle-upon-Tyne Hospitals NHS Trust; Cardiff and Vale University Health Board; Royal Brompton & Harefield NHS Foundation Trust; Erasmus University Rotterdam; Medizinische Hochschule Brandenb...
Source: ClinicalTrials.gov - August 10, 2023 Category: Research Source Type: clinical trials
Duroplasty for injured cervical spinal cord with uncontrolled swelling: protocol of the DISCUS randomized controlled trial
DiscussionWe anticipate that the addition of duroplasty to standard of care will improve muscle strength; this has benefits for patients and carers, as well as substantial gains for health services and society including economic implications. If the addition of duroplasty to standard treatment is beneficial, it is anticipated that duroplasty will become standard of care.Trial registrationIRAS: 292031 (England, Wales, Northern Ireland) - Registration date: 24 May 2021, 296518 (Scotland), ISRCTN: 25573423 (Registration date: 2 June 2021); ClinicalTrials.gov number : NCT04936620 (Registration date: 21 June 2021); NIHR CRN 486...
Source: Trials - August 7, 2023 Category: Research Source Type: clinical trials
PROPEL-2: Prophylactic Negative Pressure Wound Therapy in Laparotomy Wounds
Conditions: Wound Surgical; Wound Infection; Cosmesis Interventions: Device: Negative Pressure Wound Therapy; Other: Standard wound dressing Sponsor: Royal College of Surgeons, Ireland Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 4, 2023 Category: Research Source Type: clinical trials
